Published in mSphere on September 13, 2017
EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet (2000) 69.26
Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics (2010) 52.01
Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics (2014) 44.23
Integrative genomics viewer. Nat Biotechnol (2011) 42.83
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem (2009) 40.90
Simple cDNA normalization using kamchatka crab duplex-specific nuclease. Nucleic Acids Res (2004) 3.99
Ten years of next-generation sequencing technology. Trends Genet (2014) 2.95
Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J Virol (2010) 2.37
A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America. PLoS One (2010) 1.99
Serious overestimation in quantitative PCR by circular (supercoiled) plasmid standard: microalgal pcna as the model gene. PLoS One (2010) 1.77
A kinetic model of quantitative real-time polymerase chain reaction. Biotechnol Bioeng (2005) 1.75
Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples. J Clin Microbiol (2011) 1.64
Sequence analysis of the human virome in febrile and afebrile children. PLoS One (2012) 1.56
Exploring the potential of next-generation sequencing in detection of respiratory viruses. J Clin Microbiol (2014) 1.38
Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling. BMC Genomics (2014) 1.37
Comparing viral metagenomics methods using a highly multiplexed human viral pathogens reagent. J Virol Methods (2014) 1.20
Selection of a cutoff value for real-time polymerase chain reaction results to fit a diagnostic purpose: analytical and epidemiologic approaches. J Vet Diagn Invest (2011) 1.17
Animal virus discovery: improving animal health, understanding zoonoses, and opportunities for vaccine development. Curr Opin Virol (2012) 1.01
Quantification bias caused by plasmid DNA conformation in quantitative real-time PCR assay. PLoS One (2011) 1.01
Identification of a novel rhabdovirus in Spodoptera frugiperda cell lines. J Virol (2014) 0.92
Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome. Hum Vaccin Immunother (2013) 0.90
Quantitative characterization of defective virus emergence by deep sequencing. J Virol (2013) 0.89
The virome: a missing component of biological interaction networks in health and disease. Genome Med (2016) 0.89
Evaluation of Unbiased Next-Generation Sequencing of RNA (RNA-seq) as a Diagnostic Method in Influenza Virus-Positive Respiratory Samples. J Clin Microbiol (2015) 0.89
Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis. Sci Rep (2015) 0.88
The sequence of sequencers: The history of sequencing DNA. Genomics (2015) 0.86
Target-dependent enrichment of virions determines the reduction of high-throughput sequencing in virus discovery. PLoS One (2015) 0.85
The integration of HPV-18 into HeLa cells has involved duplication of part of the viral genome as well as human DNA flanking sequences. Nucleic Acids Res (1987) 0.82
Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products. Vaccine (2014) 0.81
Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing. Vaccine (2015) 0.80
Evaluation of the broad-range PCR-electrospray ionization mass spectrometry (PCR/ESI-MS) system and virus microarrays for virus detection. Viruses (2014) 0.80
Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products. Biologicals (2011) 0.79
Testing considerations for novel cell substrates: a regulatory perspective. PDA J Pharm Sci Technol (2011) 0.78
Adventitious agents in viral vaccines: lessons learned from 4 case studies. Biologicals (2014) 0.78
Identification of HPV integration and gene mutation in HeLa cell line by integrated analysis of RNA-Seq and MS/MS data. J Proteome Res (2015) 0.77
Current testing methods and challenges for detection of adventitious viruses. PDA J Pharm Sci Technol (2012) 0.77
Steps Used by the BLAST Algorithm. CSH Protoc (2007) 0.77
Advanced Virus Detection Technologies Interest Group (AVDTIG): Efforts for High Throughput Sequencing (HTS) for Virus Detection. PDA J Pharm Sci Technol (2016) 0.77
PDA/FDA Adventitious Agents and Novel Cell Substrates: Emerging Technologies and New Challenges, Nov. 3-4, 2011, Rockville, MD. PDA J Pharm Sci Technol (2012) 0.77
Cataloguing the taxonomic origins of sequences from a heterogeneous sample using phylogenomics: applications in adventitious agent detection. PDA J Pharm Sci Technol (2014) 0.76
Need for new technologies for detection of adventitious agents in vaccines and other biological products. PDA J Pharm Sci Technol (2014) 0.76
Identification and quantitation of Vesivirus 2117 particles in bioreactor fluids from infected Chinese hamster ovary cell cultures. Biotechnol Bioeng (2012) 0.76
Regulatory considerations for raw materials used in biological products. PDA J Pharm Sci Technol (2011) 0.76